{"id":"W2119369919","doi":"10.1371/journal.pmed.1001054","title":"Global Pharmacovigilance for Antiretroviral Drugs: Overcoming Contrasting Priorities","year":2011,"lang":"en","type":"article","venue":"PLoS Medicine","topic":"Pharmaceutical Economics and Policy","field":"Economics, Econometrics and Finance","cited_by":23,"is_retracted":false,"has_abstract":true,"ca_institutions":"","funders":"National Institute of Allergy and Infectious Diseases; Ministério da Saúde; Centers for Disease Control and Prevention; U.S. President’s Emergency Plan for AIDS Relief; amfAR, The Foundation for AIDS Research; Kaiser Permanente; European Commission; World Health Organization; National Institutes of Health; United States Agency for International Development; Global Fund to Fight AIDS, Tuberculosis and Malaria; University of Washington; York University; Bristol-Myers Squibb; Pfizer; Bill and Melinda Gates Foundation; Gilead Sciences; Incyte; U.S. Department of State","keywords":"Pharmacovigilance; Global health; Stakeholder; ANTIRETROVIRAL AGENTS; Medicine; Human immunodeficiency virus (HIV); Antiretroviral therapy; Drug; Public health; Pharmacology; Political science; Family medicine; Public relations","routes":{"ca_aff":false,"ca_fund":true,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":true},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004247473,0.0001843505,0.0005363253,0.00008995585,0.0001099548,0.00001958503,0.0002490767,0.00006760558,0.0005927594],"category_scores_gemma":[0.0002995299,0.0001955719,0.00009262597,0.0001273488,0.000150788,0.0002055375,0.00004620614,0.0001122166,0.00009759696],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.000124951,"about_ca_system_score_gemma":0.00002309649,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.000176645,"about_ca_topic_score_gemma":0.000003588794,"domain_scores_codex":[0.9984982,0.000008775576,0.0006454842,0.0003490659,0.0000332708,0.0004651778],"domain_scores_gemma":[0.9992102,0.0001276227,0.0002712379,0.0001797537,0.00003132483,0.0001798459],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"theoretical_or_conceptual","study_design_gemma":"theoretical_or_conceptual","study_design_scores_codex":[0.0002421387,0.0001732777,0.2311793,0.0003064278,0.0002985878,0.000007795399,0.002664993,0.000003548177,0.0003155332,0.7506019,0.008354271,0.005852261],"study_design_scores_gemma":[0.02138454,0.001791117,0.05065063,0.000553015,0.0002842346,0.00003252376,0.0009307434,0.07793283,0.003485112,0.4694104,0.3711844,0.00236048],"study_design_candidate":"theoretical_or_conceptual","study_design_consensus":"theoretical_or_conceptual","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.6538466,0.005735556,0.004605329,0.002622652,0.001944589,0.0008142271,0.0008912394,0.0001744192,0.3293654],"genre_scores_gemma":[0.9931613,0.0002906772,0.0009482403,0.004286769,0.000957911,0.00003999463,0.00001152914,0.00002438472,0.0002791446],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.3628301,"threshold_uncertainty_score":0.7975191,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.134963732930019,"score_gpt":0.3144939532042135,"score_spread":0.1795302202741945,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}